Accelerated tryptophan degradation in trauma and sepsis patients is related to pro-inflammatory response and to the diminished in vitro response of monocytes

Pteridines

Volumn 20, Issue 2, 2009, Pages 54-61

  Ploder, Martin ^a   Spittler, Andreas ^c   Schroecksnadel, Katharina ^d   Neurauter, Gabriele ^d   Pelinka, Linda E ^b   Roth, Erich ^c   Fuchs, Dietmar ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^c FEDERAL RESEARCH AND TRAINING CENTRE FOR FORESTS   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Indoleamine (2,3) dioxygenase; Interleukin 6, tumor necrosis factor , trauma; Kynurenine; Neopterin; Sepsis; Survival; Tryptophan

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; KYNURENINE; LIPOPOLYSACCHARIDE; NEOPTERIN; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FATALITY; FEMALE; FOLLOW UP; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; INJURY; MALE; MONOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; SEPSIS; SURVIVAL;

EID: 69149099133     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.2009.20.1.54     Document Type: Article

References (32)

1. Zedler S, Faist E. The impact of endogenous triggers on trauma-associated inflammation. Curr Opin Crit Care 2006;12:595-601. (Pubitemid 44673437)
2. Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 1991;5:2516-2522.
3. Brown RR, Ozaki Y, Datta SP, Borden EC, Sondel PM, Malone DG. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv Exp Med Biol 1991;294:425-435
4. Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984;81;908-912. (Pubitemid 14197611)
5. Carlin JM, Ozaki Y, Byrne GI, Brown RR, Borden EC. Interferons and indoleamine 2.3-dioxygenase: role in antimicrobial and antitumor effects. Experientia 1989;45:535-541. (Pubitemid 19151363)
6. Mellor AL Munn DH. Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation? Immunol Today 1999;20:469-473.
7. Pellegrin K, Neurauter G, Wirleitner B, Fleming AW, Peterson VM, Fuchs D. Enhanced enzymatic degradation of tryptophan by indoleamine 23-dioxygenase contributes to the tryptophan-deficient state seen after major trauma. Shock 2005;23:209-215. (Pubitemid 40293819)
8. Ploder M Spittler A Schroecksnadel K Neurauter G Pelinka LE Roth E Fuchs D. Tryptophan degradation in multiple trauma patients: survivors versus non-survivors. Clin Sci (Lond) 2009;116:593-598.
9. Strohmaier W, Redl H, Schlag G, Inthorn D. D-erythro-neopterin plasma levels in intensive care patients with and without septic complications. Crit Care Med 1987;15:757-760. (Pubitemid 18055662)
10. Hensler T, Sauerland S, Lefering R, Nagelschmidt M, Bouillon B, Andermahr J, Neugebauer E. A, The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 2003;20:420-426.
11. Weiss G, Murr C, Zoller H, Haun M, Widner B, Ludescher C, Fuchs D. Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 1999;116:435-440. (Pubitemid 29258092)
12. Wirleitner B, Reider D, Ebner S, Böck G, Widner B, Jaeger M, Schennach H, Romani N, Fuchs D. Monocyte-derived dendritic cells release neopterin. J Leukocyte Biol 2002;72:1148-1153. (Pubitemid 36008885)
13. Fuchs D, Moeller AA, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Lett 1991;28:207-211.
14. Wirleitner B, Neurauter G, Schröcksnadel K, Frick B, Fuchs D. Interferon- -induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr Med Chem 2003;10:1581-1591. (Pubitemid 36896559)
15. Pertovaara M, Raitala A, Juonala M, Lehtimäki T, Huhtala H, Oja SS, Jokinen E, Viikari JS, Raitakari OT, Hurme M. Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 2007;148:106-111. (Pubitemid 46364993)
16. Pertovaara M, Raitala A, Uusitalo H, Pukander J, Helin H, Oja SS, Hurme M. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjogren's syndrome. Clin Exp Immunol 2005;142:155-161. (Pubitemid 41361019)
17. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 2002;17:463-467.
18. McDaniel DO, Hamilton J, Brock M, May W, Calcote L, Tee LY, Vick L, Newman DB, Vick K, Harrison S, Timberlake G, Toevs C. Molecular analysis of inflammatory markers in trauma patients at risk of postinjury complications. J Trauma 2007;63:147-157. (Pubitemid 47057577)
19. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler 1989;370:1063-1069. (Pubitemid 19230341)
20. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997;43:2424-2426. (Pubitemid 28022985)
21. Laich A, Neurauter G, Widner B, Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 2002;48:579-581. (Pubitemid 34174597)
22. Ploder M, Pelinka L, Schmuckenschlager C, Wessner B, Ankersmit HJ, Fuerst W, Redl H, Roth E, Spittler A. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 2006;25:129-134. (Pubitemid 43755966)
23. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metabol 2002;3:175-187. (Pubitemid 34326529)
24. Billiau A. Gamma-interferon: the match that lights the fire? Immunol Today 1988;9:37-40.
25. Giusti RM, Maloney EM, Hanchard B, Morgan OSC, Steinberg SM, Wachter H, Williams E, Cranston B, Fuchs D, Manns A. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic pararesis and adult T-cell leukemia/lymphoma. Cancer Epidemiol Biomarkers Prevent 1996;5:699-709. (Pubitemid 26304644)
26. Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Goebel G, Margreiter R, Königsrainer A, Fuchs D, Amberger A. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 2006;12:1144-1151. (Pubitemid 43342502)
27. Weinlich G, Murr C, Richardsen L, Winkler C, Fuchs D, Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients. Dermatology 2007;214:8-14. (Pubitemid 46032994)
28. Boasso A, Shearer GM. How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Curr Drug Metab 2007;8:217-223. (Pubitemid 46628287)
29. Schroecksnadel K, Zangerle R, Bellmann-Weiler R, Garimorth K, Weiss G, Fuchs D. Indoleamine-2,3-dioxygenase and other interferon- -mediated pathways in patients with human immunodeficiency virus infection. Curr Drug Metab 2007;8:225-236. (Pubitemid 46621672)
30. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002;196:447-457. (Pubitemid 34940984)
31. Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D, Neopterin production tryptophan degradation and mental depression: what is the link? Brain Behav Immun 2002;16:590-595.
32. Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H, Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J. Affect. Disord 2007;98:143-151. (Pubitemid 46048912)